Stay updated with breaking news from Optimizerx Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will report earnings of $0.19 per share for the current quarter, Zacks reports. Three analysts have made estimates for OptimizeRx’s earnings. The lowest EPS estimate is $0.18 and the highest is $0.19. OptimizeRx reported earnings per share of $0.03 in the same quarter last year, which […]
OptimizeRx Co. (NASDAQ:OPRX – Get Rating) – Equities research analysts at William Blair raised their Q3 2023 earnings estimates for shares of OptimizeRx in a research report issued on Tuesday, March 29th. William Blair analyst R. Daniels now forecasts that the company will earn $0.20 per share for the quarter, up from their prior forecast […]
OptimizeRx Co. (NASDAQ:OPRX – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $41.37, but opened at $40.20. OptimizeRx shares last traded at $40.05, with a volume of 835 shares traded. Several research firms have weighed in on OPRX. TheStreet lowered shares of OptimizeRx from a “b-” […]
Precision Wealth Strategies LLC increased its stake in OptimizeRx Co. (NASDAQ:OPRX – Get Rating) by 61.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,929 shares of the company’s stock after acquiring an additional 3,783 shares during the quarter. Precision Wealth Strategies LLC owned […]
Wall Street brokerages predict that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will report $14.92 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for OptimizeRx’s earnings, with the highest sales estimate coming in at $15.19 million and the lowest estimate coming in at $14.60 million. OptimizeRx reported […]